Updates in interventional cardiology in children with cardiac disease.

The field of pediatric and congenital interventional cardiology is advancing rapidly, with recent innovations such as patent ductus arteriosus closure in premature infants, expanded options for transcatheter pulmonary valve replacement, ductal stenting for ductal-dependent lesions, and the development of novel, pediatric-specific devices. Despite these advancements, significant variability in care persists across centers, largely due to the absence of standardized guidelines. This gap can be addressed through the use of registries and multicenter studies, which offer evidence-based insights into optimal management strategies for congenital heart disease.

conclusionThis review aims to spotlight emerging procedures and devices used in the catheterization lab, presenting clinically relevant data on cutting-edge transcatheter interventions. Additionally, we discuss areas of ongoing debate and propose future research directions to further refine and standardize pediatric interventional cardiology practices. WHAT IS KNOWN: • Transcatheter procedures in congenital heart disease are growing in breadth and complexity. WHAT IS NEW: • There is significant variability in management strategies within pediatric interventional cardiology that can be addressed using registries and multicenter studies. • Novel devices like new self-expanding pulmonary valves, bioresorbable stents, and pediatric specific devices are being developed.